These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
758 related articles for article (PubMed ID: 17824581)
61. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial. Capizzi R; Landi F; Milani M; Amerio P Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558 [TBL] [Abstract][Full Text] [Related]
62. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes. Leyden JJ Cutis; 2002 Jun; 69(6):475-80. PubMed ID: 12078851 [TBL] [Abstract][Full Text] [Related]
63. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris. Dhawan SS Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284 [TBL] [Abstract][Full Text] [Related]
64. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial. Prasad S; Mukhopadhyay A; Kubavat A; Kelkar A; Modi A; Swarnkar B; Bajaj B; Vedamurthy M; Sheikh S; Mittal R Indian J Dermatol Venereol Leprol; 2012; 78(4):459-67. PubMed ID: 22772617 [TBL] [Abstract][Full Text] [Related]
65. Effect of adapalene 0.1%/benzoyl peroxide 2.5% topical gel on quality of life and treatment adherence during long-term application in patients with predominantly moderate acne with or without concomitant medication - additional results from the non-interventional cohort study ELANG. Gollnick HP; Friedrich M; Peschen M; Pettker R; Pier A; Streit V; Jöstingmeyer P; Porombka D; Rojo Pulido I; Jäckel A J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 4():23-9. PubMed ID: 26059731 [TBL] [Abstract][Full Text] [Related]
66. How patients experience and manage dryness and irritation from acne treatment. Feldman SR; Chen DM J Drugs Dermatol; 2011 Jun; 10(6):605-8. PubMed ID: 21637901 [TBL] [Abstract][Full Text] [Related]
67. Gender as a clinically relevant outcome variable in acne: benefits of a fixed combination clindamycin phosphate (1.2%) and benzoyl peroxide (2.5%) aqueous gel. Harper JC J Drugs Dermatol; 2012 Dec; 11(12):1440-5. PubMed ID: 23377514 [TBL] [Abstract][Full Text] [Related]
68. Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. Thiboutot D; Gold MH; Jarratt MT; Kang S; Kaplan DL; Millikan L; Wolfe J; Loesche C; Baker M Cutis; 2001 Oct; 68(4 Suppl):10-9. PubMed ID: 11845943 [TBL] [Abstract][Full Text] [Related]
69. Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne. Liu H; Yu H; Xia J; Liu L; Liu GJ; Sang H; Peinemann F Cochrane Database Syst Rev; 2020 May; 5(5):CD011368. PubMed ID: 32356369 [TBL] [Abstract][Full Text] [Related]
70. Compared efficacy and safety of tretinoin 0.1% microsphere gel alone and in combination with benzoyl peroxide 6% cleanser for the treatment of acne vulgaris. Shalita AR; Rafal ES; Anderson DN; Yavel R; Landow S; Lee WL Cutis; 2003 Aug; 72(2):167-72. PubMed ID: 12953944 [TBL] [Abstract][Full Text] [Related]
71. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg. Gold LS; Cruz A; Eichenfield L; Tan J; Jorizzo J; Kerrouche N; Dhuin JC Cutis; 2010 Feb; 85(2):94-104. PubMed ID: 20349684 [TBL] [Abstract][Full Text] [Related]
72. Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study. Fleischer AB; Shalita A; Eichenfield LF; Abramovits W; Lucky A; Garrett S; J Drugs Dermatol; 2010 Jan; 9(1):33-40. PubMed ID: 20120423 [TBL] [Abstract][Full Text] [Related]
73. Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial. Tanghetti E; Abramovits W; Solomon B; Loven K; Shalita A J Drugs Dermatol; 2006 Mar; 5(3):256-61. PubMed ID: 16573259 [TBL] [Abstract][Full Text] [Related]
74. Safety and efficacy of micronized tretinoin gel (0.05%) in treating adolescent acne. Torok HM; Pillai R J Drugs Dermatol; 2011 Jun; 10(6):647-52. PubMed ID: 21637905 [TBL] [Abstract][Full Text] [Related]
75. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris. Tanghetti E; Dhawan S; Torok H; Kircik L Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195 [TBL] [Abstract][Full Text] [Related]
76. The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel. Bucks D; Sarpotdar P; Yu K; Angel A; Del Rosso J J Drugs Dermatol; 2009 Jul; 8(7):634-8. PubMed ID: 19588639 [TBL] [Abstract][Full Text] [Related]
77. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris. Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775 [TBL] [Abstract][Full Text] [Related]
78. The BEST study: evaluating efficacy by selected demographic subsets. Fernandez-Obregon A; Davis MW Cutis; 2003 Feb; 71(2 Suppl):18-26. PubMed ID: 12630671 [TBL] [Abstract][Full Text] [Related]